Stock SUPRIYA SUPRIYA LIFESCIENCE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Supriya Lifescience Limited

Equities

SUPRIYA

INE07RO01027

End-of-day quote NSE India S.E.
Other stock markets
 18:00:00 2024-06-10 EDT 		5-day change 1st Jan Change
374.9 INR +2.15% Intraday chart for Supriya Lifescience Limited +11.28% +19.11%
05-28 Supriya Lifescience Limited Approves Executive Changes CI
05-28 Supriya Lifescience Limited Recommends Final Dividend for the Fiscal 2024 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Supriya Lifescience Limited Recommends Final Dividend for the Fiscal 2024
CI
Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Supriya Lifescience Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Supriya Lifescience Limited Announces Approval of Capital Expenditure at Ambernath Site for CDMO Facility
CI
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Supriya Lifescience Gets Brazil's Health Authority's GMP Certification for Site in India
MT
Supriya Lifescience Ltd Signs Agreement with Kalinga Institute of Technology for Further Development of Wound Healing Gel
CI
Supriya Lifescience Ties Up with Kalinga Institute for Oral Cancer Detection Kit
MT
Supriya Lifescience Ltd Collaborates with Kalinga Institute of Industrial Technology to Develop One of its Kind Oral Cancer Detection Kit Named Quickblue Oral Kit
CI
Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Supriya Lifescience Ltd. and Plasma Nutrition, Inc Announce Collaboration in Protein Technology
CI
Supriya Lifescience Limited Executes A Long-Term Supply and Sales Agreement with A Leading Company in Europe for the Supply of Active Pharmaceutical Ingredient
CI
Supriya Lifescience Limited Recommends Final Dividend for the Year Ended March 31, 2023
CI
Supriya Lifescience Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 30, 2022
CI
Supriya Lifescience's API Facility in Lote, India Gets European Certification
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUPRIYA Stock
  4. News Supriya Lifescience Limited
  5. Highlights